Icon

BORTEZOMIB (nda205004)- (3.5MG/VIAL)

BORTEZOMIB FRESENIUS KABI USA
3.5MG/VIAL
No Yes
2032-Nov-03 Expired
None None
None No
BORTEZOMIB is a proteasome inhibitor indicated for: • treatment of adult patients with multiple myeloma • treatment of adult patients with mantle cell lymphoma.
0 0 0
Total Other Developers None
Drugs with Suitability No
3.5MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.